A Phase 1, Open-Label, Dose Escalation Study Evaluating the Safety, Tolerability and Pharmacokinetics of AMG 655 in Subjects with Advanced Tumors.
Phase of Trial: Phase I
Latest Information Update: 24 Mar 2011
At a glance
- Drugs Conatumumab (Primary)
- Indications Hodgkin's disease; Non-Hodgkin's lymphoma; Solid tumours
- Focus Adverse reactions; Pharmacokinetics
- 31 Jul 2006 New trial record.